Volume 32, issue 7, September 2025

ÉDITORIAL

Has the time eventually come for drug treatment of cachexia in our patients with digestive cancer? (p.625-32)
Géraldine M. Camilleri, Eléa Janvier, Cindy Neuzillet, Bruno Raynard
Free Access

MINI-REVUES

Pre-surgical biliary drainage of perihilar cholangiocarcinoma: oncological and technical issues. What does the surgeon expect from the drainage of a perihilar cholangiocarcinoma? (p.633-41)
Jonathan Garnier, Yanis Dahel, Anais Palen, Jean-Philippe Ratone, Solene Hoibian, Jacques Ewald, Olivier Turrini, Fabrice Caillol

Artificial intelligence in severe acute pancreatitis: game changer or hype? (p.642-9)
Sébastien Frey, Rayan Rassouli, Ezem Sura Ekmekci, Eve Gelsi, Pierre Mayer, Philippe Grandval

Patient therapeutic education and IBD: where are we now? (p.650-7)
Xavier Hébuterne, Aude Rachart, Adrien Nicolau

Maintenance treatment in unresectable metastatic colorectal cancer (p.658-68)
Charbel Soueidy, Valérie Boige

Advanced gastrointestinal stromal tumours (GIST): a short review (p.669-76)
Octave Letissier, Samuel Le Sourd, Astrid Lièvre, Emeric Boisteau, Julien Edeline, Vincent Hautefeuille, Olivier Bouché, Christophe Perrin, Marc Pracht

Chronology of an IBD patient undergoing anti-TNF therapy (p.677-82)
Adil Soualy

Dossier thématique : Les nouveaux marqueurs en oncologie digestive

Pré-test (p.684-5)

Mise au point

Biomarkers for digestive cancers in 2025: revisiting the basics and learning the new (p.686-711)
Erwan Vo-Quang, Coralie Prévost, Anne-Cécile Brunac, Simon Garinet, Thibault Mazard, Arnaud Uguen, Nadim Fares, Frédéric Bibeau, Cindy Neuzillet, Claire Gallois, Rosine Guimbaud, Hélène Blons, Janick Selves

Cas clinique

Metastatic gastric cancer: increasingly personalized medicine (p.712-7)
Marie Muller, Florence Renaud, Aziz Zaanan

Revue bibliographique

What’s new concerning microsatellite instability in digestive tumours? (p.718-22)
David Tougeron

Entretien avec l'expert

Which biomarkers will be useful for the management of colorectal cancer patients in 2025 or in the near future? (p.723-7)
Julien Taieb

Post-test (p.728-32)

CONCEPTS ET PRATIQUE

Is it time to move to EUS-guided liver biopsy? (p.733-6)
Rémi Collin, Paul Carrier, Jérémie Albouys, Jérémie Jacques

Positive FIT, negative colonoscopy: should gastroscopy be next? (p.737-40)
Marc Harb, Alexandre Nuzzo

Surgery and Chronic pancreatitis. The earlier the better! (p.741-5)
Renato Micelli Lupinacci, Pierre Mayer, Philippe Grandval

Organ preservation and rectal cancer: yes, but planned, not opportunistic! (p.746-52)
David Sefrioui

“Low to moderate” alcohol consumption is associated with a more severe liver disease in patients with MAFLD (p.753-7)
Alexandre Pariente

LETTRES À LA RÉDACTION

And you, what would you have done in front of an immune-induced myasthenia gravis? (p.758-60)
Lisa Avoic, Alexandra Fambrini, Jean-Philippe Camdessanche, Jean-Marc Phelip, Nicolas Williet

Emphysematous hepatitis: a very rare, often fatal disease (p.761-3)
Yesso Agoua, Thomas Hunaut, Alexandra Heurgué

A Perianal Rarity: granular cell tumor (Abrikossoff Tumor) (p.764-6)
Audrey Soulabaille, Amélie Barré, Édouard Chambenois, Julien Adam, Vincent de Parades

BRÈVE D’HISTOIRE

The brilliant Brillat-Savarin (p.767-9)
Anne-Marie Marion-Audibert

INJECTIONS DE RAPPEL

● À retenir du n°6 Juin 2025 (p.770-3)